Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.67 |
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.65 |
| ▸ | SIGMAR1 known ✓ | Q99720 | 4/20 | 0.59 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.50 |
| ▸ | HDAC3 known ✓ | O15379 | 1/20 | 0.49 |
| ▸ | HDAC1 known ✓ | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC2 known ✓ | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC8 known ✓ | Q9BY41 | 1/20 | 0.49 |
| ▸ | ACHE known ✓ | P22303 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2790069 | 0.98 | MAOA (0.69) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Water SCHEMBL8529965 | 0.98 | MAOA (0.69) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL767526 | 0.98 | MAOA (0.69) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Water SCHEMBL8528419 | 0.98 | MAOA (0.69) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL10584193 | 0.98 | MAOA (0.69) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL2789724 | 0.98 | MAOA (0.69) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL199811 | 0.98 | MAOA (0.69) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Water SCHEMBL8529245 | 0.98 | MAOA (0.69) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL28399413 | 0.98 | MAOA (0.69) | MAOACHRM2SIGMAR1MEN1KMT2A | |
| SCHEMBL7861380 | 0.97 | MAOA (0.71) | MAOACHRM2SIGMAR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048034-A1 | COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF DICARBOXYLIC ACID ESTERS, AND USES THEREOF | NEW FRONTIER LABS LLC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4696307-A1 | COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF DICARBOXYLIC ACID ESTERS, AND USES THEREOF | New Frontier Labs, LLC (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-2905361-B1 | METHOD OF FORMING A METAL COATING | TOYOTA MOTOR CO LTD (JP) | 2022-01-05 | — | — | EP | disclosed |
| US-10703959-B2 | Functionalized silicate nanoparticle composition, removing and exfoliating asphaltenes with same | BAKER HUGHES, A GE COMPANY, LLC (US) | 2020-07-07 | — | — | US | disclosed |
| US-20170247599-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED | 2017-08-31 | — | — | US | disclosed |
| US-9708723-B2 | Electroplating cell, and metal coating and method of forming the same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9683163-B2 | Functionalized silicate nanoparticle composition, removing and exfoliating asphaltenes with same | BAKER HUGHES INCORPORATED (US) | 2017-06-20 | — | — | US | disclosed |
| EP-2038701-B1 | ENCAPSULATED DISPERSIONS COMPRISING ELECTROPHORETICALLY MOBILE ORGANIC COLORANTS | BASF SE (DE) | 2017-04-12 | — | — | EP | disclosed |
| WO-2016149454-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2016-09-22 | — | — | WO | disclosed |
| EP-2363498-B1 | METHOD FOR QUANTITATIVELY DETERMINING CHOLESTEROL IN LOW-DENSITY LIPOPROTEINS, REAGENT FOR QUANTITATIVE DETERMINATION, AND QUANTITATIVE DETERMINATION KIT | KYOWA MEDEX CO LTD (JP) | 2016-05-25 | — | — | EP | disclosed |
| US-8040592-B2 | Encapsulated dispersions comprising electrophoretically mobile organic colorants | BASF SE (DE) | 2011-10-18 | — | — | US | disclosed |
| US-20110223626-A1 | METHOD FOR QUANTITATIVELY DETERMINING CHOLESTEROL IN LOW-DENSITY LIPOPROTEINS,REAGENT FOR QUANTITATIVE DETERMINATION,AND QUANTITATIVE DETERMINATION KIT | KYOWA MEDEX CO., LTD. (JP) | 2011-09-15 | — | — | US | disclosed |
| EP-2363498-A1 | METHOD FOR QUANTITATIVELY DETERMINING CHOLESTEROL IN LOW-DENSITY LIPOPROTEINS, REAGENT FOR QUANTITATIVE DETERMINATION, AND QUANTITATIVE DETERMINATION KIT | Kyowa Medex CO., LTD. (JP) | 2011-09-07 | — | — | EP | disclosed |
| US-20100265564-A1 | Encapsulated dispersions comprising electrophoretically mobile organic colorants | CIBA CORPORATION | 2010-10-21 | — | — | US | disclosed |
| EP-2038701-A2 | ENCAPSULATED DISPERSIONS COMPRISING ELECTROPHORETICALLY MOBILE ORGANIC COLORANTS | Ciba Holding Inc. (CH) | 2009-03-25 | — | — | EP | disclosed |
| WO-2008003619-A2 | ENCAPSULATED DISPERSIONS COMPRISING ELECTROPHORETICALLY MOBILE ORGANIC COLORANTS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| US-7060121-B2 | Method of producing gold nanoparticle | LIN HSING KUANG | 2006-06-13 | — | — | US | disclosed |
| US-20040261574-A1 | Method of producing gold nanoparticle | LIN HSING KUANG (US) | 2004-12-30 | — | — | US | disclosed |
| US-5308735-A | Aromatic-aldehyde resins, improved solubility | NIPPON PAINT CO., LTD. (JP) | 1994-05-03 | — | — | US | disclosed |
| EP-0540016-A1 | Photosensitive resin and resin composition for lithographic printing | Nippon Paint Co., Ltd. (JP) | 1993-05-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048034-A1 | COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF DICARBOXYLIC ACID ESTERS, AND USES THEREOF | PLA2G12A, DAGLA, PLA2G2E | MAOA 2882/4885CHRM2 126/4885SIGMAR1 2912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.